Neuroscience
Reuptake
100%
Reuptake Inhibitor
100%
Pharmacokinetics
100%
Conditioned Place Preference
100%
Serotonin
50%
Nucleus Accumbens
50%
Microdialysis
50%
Treatment of Depression
50%
Norepinephrine
50%
Receptor Occupancy
50%
Monoamines Receptor
50%
Keyphrases
Cocaine
100%
Addiction
100%
DOV 216,303
100%
Dopamine
27%
Pharmacokinetic Profile
18%
Hyperlocomotion
18%
Effective Dose
18%
Place Preference
18%
Conditioned Place Preference
18%
Triple Reuptake Inhibitor
18%
Drug-induced
9%
Future Therapeutics
9%
Nucleus Accumbens
9%
Addictive Drugs
9%
Microdialysis
9%
Dopamine Level
9%
Depression Treatment
9%
Reuptake
9%
High Dose
9%
Acute Administration
9%
Noradrenaline
9%
Mechanism of Action
9%
Occupancy
9%
Receptor Occupancy
9%
Copyright
9%
Monoamine Receptors
9%
Dopamine Reuptake
9%
Depression Model
9%
Therapeutic Use
9%
Dose-ranging
9%
Adult Mice
9%
Extracellular Concentration
9%
Serotonin Reuptake
9%
Self-administration
9%
Brain Exposure
9%
Abuse Potential
9%
Low Potential
9%
Plasma Exposure
9%
Rewarding Effect
9%
Preference Modeling
9%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Pharmacokinetics
66%
Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor
66%
Serotonin
33%
Receptor
33%
Noradrenalin
33%
Monoamine
33%
Microdialysis
33%
Therapeutic Use
33%